Contact
searchSearch
HMP Global

Skin Cancer

Featured

Jessica Weiser
Videos
Bemotrizinol and UVA Protection: Why This New Sunscreen Filter Matters
07/01/2026
Jessica Weiser, MD, FAAD; Riya Gandhi, MA
Dr Jessica Weiser discusses the FDA approval of bemotrizinol, the first new sunscreen active ingredient added to the US sunscreen monograph in more than 20 years.
Dr Jessica Weiser discusses the FDA approval of bemotrizinol, the first new sunscreen active ingredient added to the US sunscreen monograph in more than 20 years.
Dr Jessica Weiser discusses the...
07/01/2026
The Dermatologist
AK
News
Tirbanibulin Maintains Durable 1-Year Efficacy With Favorable Safety in Actinic Keratosis Real-World Study
03/31/2026
Riya Gandhi, MA
Extension data show sustained clearance in most lesions, with no late safety concerns and support for repeat treatment strategies.
Extension data show sustained clearance in most lesions, with no late safety concerns and support for repeat treatment strategies.
Extension data show sustained...
03/31/2026
The Dermatologist
News
Tirbanibulin Demonstrates Significant Lesion Reduction and Favorable Safety in Actinic Keratosis Over Larger Treatment Fields
03/30/2026
Riya Gandhi, MA
Phase 3 data show strong efficacy and tolerability of tirbanibulin across treatment areas up to 100 cm², including with repeat treatment courses.
Phase 3 data show strong efficacy and tolerability of tirbanibulin across treatment areas up to 100 cm², including with repeat treatment courses.
Phase 3 data show strong...
03/30/2026
The Dermatologist
skin cancer
News
Phase 3 Trial Demonstrates Significant Benefits of Libtayo in High-Risk Cutaneous Squamous Cell Carcinoma
01/14/2025
Jessica Garlewicz
Regeneron Pharmaceuticals has announced promising interim results from the Phase 3 C-POST trial, evaluating the PD-1 inhibitor Libtayo (cemiplimab).
Regeneron Pharmaceuticals has announced promising interim results from the Phase 3 C-POST trial, evaluating the PD-1 inhibitor Libtayo (cemiplimab).
Regeneron Pharmaceuticals has...
01/14/2025
The Dermatologist
doctor
News
Pongamia Pinnata Extract as a Potential Treatment for Skin Cancer
12/30/2024
Riya Gandhi, MA
New research reveals Pongamia pinnata’s powerful potential as an anti-cancer agent for skin tumors, combining traditional knowledge with cutting-edge molecular science.
New research reveals Pongamia pinnata’s powerful potential as an anti-cancer agent for skin tumors, combining traditional knowledge with cutting-edge molecular science.
New research reveals Pongamia...
12/30/2024
The Dermatologist
skin cancer
News
Non-Melanoma Skin Cancer Event Rates: Considerations for Clinical Trial Design
08/22/2024
Jessica Garlewicz
Researchers investigated clinical risk factors and event rates for the development of new non-melanoma skin cancer.
Researchers investigated clinical risk factors and event rates for the development of new non-melanoma skin cancer.
Researchers investigated...
08/22/2024
The Dermatologist
skin cancer
News
Skin Cancers Associated with Genodermatoses in Patients with Skin of Color
08/09/2024
Jessica Garlewicz
Researchers aimed to identify notable characteristics in location, frequency, and severity of cutaneous findings, along with the median age of skin cancers in patients with skin of color.
Researchers aimed to identify notable characteristics in location, frequency, and severity of cutaneous findings, along with the median age of skin cancers in patients with skin of color.
Researchers aimed to identify...
08/09/2024
The Dermatologist
skin cancer
News
Esophageal Squamous Cell Carcinoma Under Iodine Staining
08/09/2024
Jessica Garlewicz
Researchers aimed to evaluate the effects of texture and color enhancement imaging on improving the endoscopic visibility of esophageal squamous cell carcinoma under iodine staining.
Researchers aimed to evaluate the effects of texture and color enhancement imaging on improving the endoscopic visibility of esophageal squamous cell carcinoma under iodine staining.
Researchers aimed to evaluate...
08/09/2024
The Dermatologist
skin cancer
News
Establishing a Novel Model for Studying Neural Invasion in Non-Melanoma Skin Cancer
05/15/2024
Jessica Garlewicz
Researchers aimed to develop a 3-dimensional model of neural invasion in squamous cell carcinoma to better understand its underlying biologic mechanisms, which are still poorly understood.
Researchers aimed to develop a 3-dimensional model of neural invasion in squamous cell carcinoma to better understand its underlying biologic mechanisms, which are still poorly understood.
Researchers aimed to develop a...
05/15/2024
The Dermatologist
skin cancer
News
Interferon-Gamma as a Prognostic Marker in Macroscopic Stage III Melanoma
05/08/2024
Jessica Garlewicz
Researchers aimed to identify prognostic and predictive biomarkers for adjuvant anti-PD-1 therapy in patients with macroscopic stage III melanoma.
Researchers aimed to identify prognostic and predictive biomarkers for adjuvant anti-PD-1 therapy in patients with macroscopic stage III melanoma.
Researchers aimed to identify...
05/08/2024
The Dermatologist
skin cancer
News
Relationship Between Insulin Use, Social Determinants of Health, and Non-Melanoma Skin Cancer
05/07/2024
Jessica Garlewicz
Researchers aimed to investigate the relationship between insulin use, social determinants of health, and non-melanoma skin cancer risk among individuals with diabetes.
Researchers aimed to investigate the relationship between insulin use, social determinants of health, and non-melanoma skin cancer risk among individuals with diabetes.
Researchers aimed to investigate...
05/07/2024
The Dermatologist

Case Reports

DID Reviewed Article
Shedding Light on Precancers
10/15/2021
Tristan M Hasbargen, MMS, PA-C
Photodynamic therapy (PDT) was a popular dermatologic treatment more than 100 years ago until newer medications came to market. Recent studies of PDT have shown some efficacy of treating actinic keratoses.
Photodynamic therapy (PDT) was a popular dermatologic treatment more than 100 years ago until newer medications came to market. Recent studies of PDT have shown some efficacy of treating actinic keratoses.
Photodynamic therapy (PDT) was a...
10/15/2021
The Dermatologist
Derm Dx
What Syndrome Caused These Palmar Pits?
09/15/2021
Melissa A. Nickles, BA; Kurt A. Ashack, MD, MHS; Amor Khachemoune, MD, FAAD, FACMS
A 14-year-old Hispanic boy presented to the dermatology clinic with multiple asymptomatic, circular indentations on both palms after immersing his hands in water.
A 14-year-old Hispanic boy presented to the dermatology clinic with multiple asymptomatic, circular indentations on both palms after immersing his hands in water.
A 14-year-old Hispanic boy...
09/15/2021
The Dermatologist
Feature Story
Using Ancillary Tests in the Diagnosis of Melanoma
09/15/2021
Linda Susan Marcus, MD, FAAD
Novel diagnostic tests may be useful in helping to detect malignancy, particularly if the test can be used by the patient remotely. Like any new therapy or technique, these tests need more study to determine their clinical utility for...
Novel diagnostic tests may be useful in helping to detect malignancy, particularly if the test can be used by the patient remotely. Like any new therapy or technique, these tests need more study to determine their clinical utility for...
Novel diagnostic tests may be...
09/15/2021
The Dermatologist
Feature Story
Mohs Surgery in a Post-COVID World: Improving Patient Outcomes in 2021
08/16/2021
Jeremy Youse, MD
Personal ancedotes and published research are starting to explore how the pandemic may have impacted skin cancer diagnosis and care. Dermatologists have to take an active role in patient outreach to improve downstream outcomes.
Personal ancedotes and published research are starting to explore how the pandemic may have impacted skin cancer diagnosis and care. Dermatologists have to take an active role in patient outreach to improve downstream outcomes.
Personal ancedotes and published...
08/16/2021
The Dermatologist
Derm Dx
What Is This Papule?
07/11/2021
Sabrina Lichon Bennett, MD; Amor Khachemoune, MD, FAAD, FACMS; Vanessa Lichon, MD; Karl Napekoski, MD
A 33-year-old woman presented to the clinic complaining of a “firm spot” on her left cheek that rapidly grew and stabilized over the course of approximately 6 weeks.
A 33-year-old woman presented to the clinic complaining of a “firm spot” on her left cheek that rapidly grew and stabilized over the course of approximately 6 weeks.
A 33-year-old woman presented to...
07/11/2021
The Dermatologist
Derm Dx
What Is the Underlying Cause of These Exophytic Lesions?
05/09/2021
A 102-year-old African American woman presented to the dermatology clinic for initial management of lesions on her right medial foot. The lesions had been present for several weeks, and the patient was unable to recall any preceding trauma,...
A 102-year-old African American woman presented to the dermatology clinic for initial management of lesions on her right medial foot. The lesions had been present for several weeks, and the patient was unable to recall any preceding trauma,...
A 102-year-old African American...
05/09/2021
The Dermatologist
Feature Story
Office-Based Surface Radiotherapy for the Dermatology Clinic: A Two-Case Study
03/12/2021
Steven A. Davis, MD
Standard of care for patients with nonmelanoma skin cancer (NMSC) remains to be surgical treatment. A number of techniques, including standard excision, Mohs micrographic surgery, and electrodesiccation and...
Standard of care for patients with nonmelanoma skin cancer (NMSC) remains to be surgical treatment. A number of techniques, including standard excision, Mohs micrographic surgery, and electrodesiccation and...
...
03/12/2021
The Dermatologist
Derm Dx
What Is This Hyperpigmented Scalp Nodule?
03/11/2021
Karen Heidelberg, MD; Adam Richardson, DO; Ciara Grayson, MD, MS
Figure 1 Case Report A 75-year-old African American woman presented to the clinic with a history of a slowly growing asymptomatic nodule on the right anterior scalp over a few months. Physical exam...
Figure 1 Case Report A 75-year-old African American woman presented to the clinic with a history of a slowly growing asymptomatic nodule on the right anterior scalp over a few months. Physical exam...
...
03/11/2021
The Dermatologist
Feature Story
Primary Cutaneous Myoepithelial Carcinoma Discovered Incidentally During Mohs Surgery
02/16/2021
Pavan K. Nootheti, MD, FAAD, FACMS; Vassiliki Papastavros, MD
Primary cutaneous myoepithelial carcinoma is very rare, with fewer than 15 cases reported in the literature to date. In our patient, primary cutaneous myoepithelial carcinoma was discovered incidentally during Mohs...
Primary cutaneous myoepithelial carcinoma is very rare, with fewer than 15 cases reported in the literature to date. In our patient, primary cutaneous myoepithelial carcinoma was discovered incidentally during Mohs...
...
02/16/2021
The Dermatologist
Feature Story
A Tender Eyebrow Nodule Heralding the Malignant Degeneration of a Spiradenoma
12/14/2020
Tesia Kolodziejczyk, BA
While uncommon, the diagnosis and treatment of cutaneous adnexal tumors such as spiradenocarcinoma are incredibly important for prognostic implications.   Spiradenocarcinomas are rare, malignant eccrine tumors...
While uncommon, the diagnosis and treatment of cutaneous adnexal tumors such as spiradenocarcinoma are incredibly important for prognostic implications.   Spiradenocarcinomas are rare, malignant eccrine tumors...
...
12/14/2020
The Dermatologist
Derm Dx
What Are These Pigmented, Pedunculated Lesions?
08/04/2026
Tanya Henry, MD; Amor Khachemoune, MD, FAAD, FACMS
A 60-year-old African American woman presented to the clinic with multiple hyperpigmented, raised papules distributed across the face and neck.
A 60-year-old African American woman presented to the clinic with multiple hyperpigmented, raised papules distributed across the face and neck.
A 60-year-old African American...
08/04/2026
The Dermatologist
Derm Dx
What Caused This Recurrent Eruption on the Neck, Ears, and Shoulders?
06/08/2026
Lanah Almatroud, BA; Amor Khachemoune, MD, FAAD, FACMS
A 29-year-old woman presented for a dermatologic evaluation with erythematous pustular lesions involving the face, ear, neck, shoulder, and scapular areas.
A 29-year-old woman presented for a dermatologic evaluation with erythematous pustular lesions involving the face, ear, neck, shoulder, and scapular areas.
A 29-year-old woman presented...
06/08/2026
The Dermatologist
Derm Dx
What Caused This Truncal Rash?
04/07/2026
George G. Papadeas, BS; Nicolia S. Christy, PA-C; Aamir N. Hussain, MD, MAPP
A 16-year-old African American adolescent boy with no known past medical history presented with a dark eruption involving the chest and abdomen ongoing for 1 year.
A 16-year-old African American adolescent boy with no known past medical history presented with a dark eruption involving the chest and abdomen ongoing for 1 year.
A 16-year-old African American...
04/07/2026
The Dermatologist
Feature Story
Biosimilars in Dermatology: What Clinicians Need to Know in 2026
03/09/2026
Omar Raheel, BA; Jade Bajic, BSc; Ryan Hirsh, BS; Steven R. Feldman, MD, PhD
Get the answers to key questions about biosimilars, including what they are, how they are regulated, and how they affect prescribing, insurance coverage, and patient care.
Get the answers to key questions about biosimilars, including what they are, how they are regulated, and how they affect prescribing, insurance coverage, and patient care.
Get the answers to key questions...
03/09/2026
The Dermatologist
Feature Story
Beyond the Gut: Recognizing and Managing Inflammatory Bowel Disease in Dermatologic Practice
03/09/2026
David Fudman, MD; Riya Gandhi, MA
Gastroenterologist Dr David Fudman examines our evolving understanding of the gut-skin axis and the pivotal role dermatologists play in identifying and comanaging the cutaneous symptoms of luminal disease.
Gastroenterologist Dr David Fudman examines our evolving understanding of the gut-skin axis and the pivotal role dermatologists play in identifying and comanaging the cutaneous symptoms of luminal disease.
Gastroenterologist Dr David...
03/09/2026
The Dermatologist
Derm Dx
What Is This Persistent Scaly Plaque in the Axilla?
03/09/2026
Aamir N. Hussain, MD, MAPP; Umayr R. Shaikh, MPH; Kabir Al-Tariq, MS; David Terrano, MD, PhD
A 55-year-old woman with a history of hypertension and nonalcoholic fatty liver disease presented with a pruritic rash localized to her right axilla for 2 months.
A 55-year-old woman with a history of hypertension and nonalcoholic fatty liver disease presented with a pruritic rash localized to her right axilla for 2 months.
A 55-year-old woman with a...
03/09/2026
The Dermatologist
HSF-Reviewed Content
From Reactive to Proactive: Building Longitudinal Care Plans That Actually Work for Hidradenitis Suppurativa
03/09/2026
Mondana Ghias, MD, FAAD
Through a longitudinal approach, care teams can achieve greater clarity, stability, and long-term disease control.
Through a longitudinal approach, care teams can achieve greater clarity, stability, and long-term disease control.
Through a longitudinal approach,...
03/09/2026
The Dermatologist
Derm Dx
What Caused These Changes on the Shins?
01/30/2026
Bruh Alem, MD; Aklilu Melaku, MD; Amor Khachemoune, MD, FAAD, FACMS
A 72-year-old man with a history of type 2 diabetes, obesity, and hypertension presented with multiple firm, well-circumscribed, reddish-brown, cystic lesions on both shins but more pronounced on his right shin.
A 72-year-old man with a history of type 2 diabetes, obesity, and hypertension presented with multiple firm, well-circumscribed, reddish-brown, cystic lesions on both shins but more pronounced on his right shin.
A 72-year-old man with a history...
01/30/2026
The Dermatologist
Derm Dx
What Is This Process That Occurs in Hairdressers?
12/09/2025
Kassidy Fishman, BBA; Stephanie Liu, DO, MBA; Robert Adler, BA; Isha Gandhi, BS; Robert Phelps, MD
A 57-year-old man who works as barber presented with a nodule on his dorsal right hand.
A 57-year-old man who works as barber presented with a nodule on his dorsal right hand.
A 57-year-old man who works as...
12/09/2025
The Dermatologist
Derm Dx
What Is This Lesion on an Older Woman’s Finger?
10/09/2025
Aaisha Jamiluddin, MS; Vrinda Deshpande, MS; Bryan Ebert, MD; Nasir Aziz, MD
An 84-year-old woman presented for evaluation of a purple lesion on her left index finger.
An 84-year-old woman presented for evaluation of a purple lesion on her left index finger.
An 84-year-old woman presented...
10/09/2025
The Dermatologist

Expert Insights

Jessica Weiser
Videos
Bemotrizinol and UVA Protection: Why This New Sunscreen Filter Matters
07/01/2026
Jessica Weiser, MD, FAAD; Riya Gandhi, MA
Dr Jessica Weiser discusses the FDA approval of bemotrizinol, the first new sunscreen active ingredient added to the US sunscreen monograph in more than 20 years.
Dr Jessica Weiser discusses the FDA approval of bemotrizinol, the first new sunscreen active ingredient added to the US sunscreen monograph in more than 20 years.
Dr Jessica Weiser discusses the...
07/01/2026
The Dermatologist
Dr Manuel Valdebran
Q&As
Sun Protective Behaviors Associated With Family History of Melanoma
04/10/2023
Riya Gandhi, MA
In this interview, Dr Manuel Valdebran discusses the association between sun protective behaviors and family history of melanoma, along with the importance of recommending alternate SPB in addition to sunscreen use.
In this interview, Dr Manuel Valdebran discusses the association between sun protective behaviors and family history of melanoma, along with the importance of recommending alternate SPB in addition to sunscreen use.
In this interview, Dr Manuel...
04/10/2023
The Dermatologist
Vernon Sondak
Q&As
Latest Advances in Melanoma Treatment
03/31/2023
Riya Gandhi, MA
In this interview, The Dermatologist met with Dr Vernon Sondak to discuss his recent session, “Update on the Latest Advances in Treatment of Melanoma,” at the 2023 AAD Annual Meeting.
In this interview, The Dermatologist met with Dr Vernon Sondak to discuss his recent session, “Update on the Latest Advances in Treatment of Melanoma,” at the 2023 AAD Annual Meeting.
In this interview, The...
03/31/2023
The Dermatologist
Dr Julia Siegel
Videos
Conversations About Photoprotection During the Pandemic
10/21/2021
Julia A. Siegel, MD
Dr Julia Siegel discusses the importance of photoprotection, sunscreen, and how the pandemic has affected patient skin exams.
Dr Julia Siegel discusses the importance of photoprotection, sunscreen, and how the pandemic has affected patient skin exams.
Dr Julia Siegel discusses the...
10/21/2021
The Dermatologist
DID Reviewed Article
Shedding Light on Precancers
10/15/2021
Tristan M Hasbargen, MMS, PA-C
Photodynamic therapy (PDT) was a popular dermatologic treatment more than 100 years ago until newer medications came to market. Recent studies of PDT have shown some efficacy of treating actinic keratoses.
Photodynamic therapy (PDT) was a popular dermatologic treatment more than 100 years ago until newer medications came to market. Recent studies of PDT have shown some efficacy of treating actinic keratoses.
Photodynamic therapy (PDT) was a...
10/15/2021
The Dermatologist
Feature Story
Using Ancillary Tests in the Diagnosis of Melanoma
09/15/2021
Linda Susan Marcus, MD, FAAD
Novel diagnostic tests may be useful in helping to detect malignancy, particularly if the test can be used by the patient remotely. Like any new therapy or technique, these tests need more study to determine their clinical utility for...
Novel diagnostic tests may be useful in helping to detect malignancy, particularly if the test can be used by the patient remotely. Like any new therapy or technique, these tests need more study to determine their clinical utility for...
Novel diagnostic tests may be...
09/15/2021
The Dermatologist
Feature Story
Mohs Surgery in a Post-COVID World: Improving Patient Outcomes in 2021
08/16/2021
Jeremy Youse, MD
Personal ancedotes and published research are starting to explore how the pandemic may have impacted skin cancer diagnosis and care. Dermatologists have to take an active role in patient outreach to improve downstream outcomes.
Personal ancedotes and published research are starting to explore how the pandemic may have impacted skin cancer diagnosis and care. Dermatologists have to take an active role in patient outreach to improve downstream outcomes.
Personal ancedotes and published...
08/16/2021
The Dermatologist
Dr Goyal-O’Leary on mycosis fungoides and melanoma
Videos
Mycosis Fungoides and Melanoma: Insights for Derm
07/13/2021
In this video Dr Goyal shares her unique tips and insights for fellow dermatologists regarding mycosis fungoides and melanoma.
In this video Dr Goyal shares her unique tips and insights for fellow dermatologists regarding mycosis fungoides and melanoma.
In this video Dr Goyal shares...
07/13/2021
The Dermatologist
Q&As
Melanoma: On the Cusp of New Advances
05/17/2021
Jessica Garlewicz
Just over the horizon of melanoma diagnosis and treatment are a number of exciting opportunities, from prevention therapeutics to telehealth. Dr Sancy Leachman shares her perspective.
Just over the horizon of melanoma diagnosis and treatment are a number of exciting opportunities, from prevention therapeutics to telehealth. Dr Sancy Leachman shares her perspective.
Just over the horizon of...
05/17/2021
The Dermatologist
Cover Story
The Fight for Photoprotection: Pushing for Increased Sunscreen Access
05/11/2021
Lauren Mateja
Photoprotection is a critical part of basic skin care, let alone skin cancer prevention. Improving access to sunscreen products, particularly when it comes to travel, could mean improved outcomes for all patients.
Photoprotection is a critical part of basic skin care, let alone skin cancer prevention. Improving access to sunscreen products, particularly when it comes to travel, could mean improved outcomes for all patients.
Photoprotection is a critical...
05/11/2021
The Dermatologist
Asempa
Videos
Myth Buster: Shared Decision-Making is Easy in Alopecia Areata
08/06/2026
Oyetewa Boluwatito Asempa, MD, FAAD; Riya Gandhi, MA
Shared decision-making in alopecia areata is often more complex than it appears. Dr Oyetewa Asempa discusses aligning treatment goals, managing expectations, and improving patient-clinician communication.
Shared decision-making in alopecia areata is often more complex than it appears. Dr Oyetewa Asempa discusses aligning treatment goals, managing expectations, and improving patient-clinician communication.
Shared decision-making in...
08/06/2026
The Dermatologist
Draelos
Videos
Myth Buster: Hair Regrowth is the Only Outcome That Matters
08/06/2026
Zoe Diana Draelos, MD; Riya Gandhi, MA
Hair regrowth is only one measure of success in alopecia areata. Dr Zoe Draelos highlights patient-centered outcomes, quality of life, emotional well-being, and long-term disease control.
Hair regrowth is only one measure of success in alopecia areata. Dr Zoe Draelos highlights patient-centered outcomes, quality of life, emotional well-being, and long-term disease control.
Hair regrowth is only one...
08/06/2026
The Dermatologist
Draelos
Videos
Myth Buster: Children are More Resilient to Alopecia Areata Than Adults
08/06/2026
Zoe Diana Draelos, MD; Riya Gandhi, MA
Pediatric alopecia areata can have profound emotional and social consequences. Dr Zoe Draelos examines the unique psychological challenges facing children and adolescents with the disease.
Pediatric alopecia areata can have profound emotional and social consequences. Dr Zoe Draelos examines the unique psychological challenges facing children and adolescents with the disease.
Pediatric alopecia areata can...
08/06/2026
The Dermatologist
Draelos
Videos
Myth Buster: Patients Will Adjust to Alopecia Areata Over Time
08/06/2026
Zoe Diana Draelos, MD; Riya Gandhi, MA
Adapting to alopecia areata isn't always a linear process. Dr Zoe Draelos discusses the lasting emotional impact of the disease and why ongoing psychosocial support remains essential.
Adapting to alopecia areata isn't always a linear process. Dr Zoe Draelos discusses the lasting emotional impact of the disease and why ongoing psychosocial support remains essential.
Adapting to alopecia areata...
08/06/2026
The Dermatologist
Asempa
Videos
Myth Buster: Dermatologists are Already Addressing the Psychosocial Burden of Alopecia Areata
08/06/2026
Oyetewa Boluwatito Asempa, MD, FAAD; Riya Gandhi, MA
Treating alopecia areata extends beyond managing hair loss. Dr Oyetewa Asempa explores gaps in psychosocial care, patient communication, and integrating mental health into clinical practice.
Treating alopecia areata extends beyond managing hair loss. Dr Oyetewa Asempa explores gaps in psychosocial care, patient communication, and integrating mental health into clinical practice.
Treating alopecia areata extends...
08/06/2026
The Dermatologist
Guttman
Videos
Myth Buster: If Treatment is Working, Patients can Stop it Immediately
08/06/2026
Emma Guttman-Yassky, MD, PhD; Riya Gandhi, MA
Successful alopecia areata treatment doesn't always mean therapy should end. Dr Emma Guttman discusses relapse risk, maintenance strategies, and setting realistic expectations for long-term disease management.
Successful alopecia areata treatment doesn't always mean therapy should end. Dr Emma Guttman discusses relapse risk, maintenance strategies, and setting realistic expectations for long-term disease management.
Successful alopecia areata...
08/06/2026
The Dermatologist
Emma Guttman
Videos
Myth Buster: Once a Patient Loses all Their Hair, Treatment Won’t Work
08/06/2026
Emma Guttman-Yassky, MD, PhD; Riya Gandhi, MA
Complete hair loss doesn't necessarily mean treatment failure in alopecia areata. Examine the latest evidence on therapeutic response, severe disease, and evolving treatment strategies.
Complete hair loss doesn't necessarily mean treatment failure in alopecia areata. Examine the latest evidence on therapeutic response, severe disease, and evolving treatment strategies.
Complete hair loss doesn't...
08/06/2026
The Dermatologist
Guttman
Videos
Myth Buster: Alopecia Areata is Just Hair Loss
08/06/2026
Emma Guttman-Yassky, MD, PhD; Riya Gandhi, MA
Alopecia areata is more than hair loss. Dr Emma Guttman discusses the disease's psychosocial burden, autoimmune nature, and why viewing AA as purely cosmetic can undermine patient care.
Alopecia areata is more than hair loss. Dr Emma Guttman discusses the disease's psychosocial burden, autoimmune nature, and why viewing AA as purely cosmetic can undermine patient care.
Alopecia areata is more than...
08/06/2026
The Dermatologist
Craiglow
Videos
Myth Buster: Alopecia Areata is No Longer an Unmet Need in Dermatology
08/06/2026
Brittany Craiglow, MD; Riya Gandhi, MA
Despite major therapeutic advances, alopecia areata remains an area of unmet need. Dr Brittany Craiglow explores ongoing challenges in treatment access, research, and long-term disease management.
Despite major therapeutic advances, alopecia areata remains an area of unmet need. Dr Brittany Craiglow explores ongoing challenges in treatment access, research, and long-term disease management.
Despite major therapeutic...
08/06/2026
The Dermatologist
Craiglow
Videos
Myth Buster: Alopecia Areata Awareness has Solved the Stigma Problem
08/06/2026
Brittany Craiglow, MD; Riya Gandhi, MA
Growing awareness of alopecia areata has improved visibility, but stigma remains. Dr Brittany Craiglow discusses persistent misconceptions, social challenges, and opportunities for better patient support.
Growing awareness of alopecia areata has improved visibility, but stigma remains. Dr Brittany Craiglow discusses persistent misconceptions, social challenges, and opportunities for better patient support.
Growing awareness of alopecia...
08/06/2026
The Dermatologist

Interactive

skin of color skin examination
Quiz
Trivia: Skin Cancer in Patients With Skin of Color
06/16/2022
Jessica Garlewicz
Are patients with skin of color excluded from getting skin cancer?
Are patients with skin of color excluded from getting skin cancer?
Are patients with skin of color...
06/16/2022
The Dermatologist
squamous cell carcinoma on head
Quiz
Trivia: Risk Factors Associated With Anxiety in Mohs Micrographic Surgery
06/09/2022
Jessica Garlewicz
Which of the following options accurately identifies risk factors associated with anxiety concerning Mohs micrographic surgery?
Which of the following options accurately identifies risk factors associated with anxiety concerning Mohs micrographic surgery?
Which of the following options...
06/09/2022
The Dermatologist
Quiz
Trivia: National Comprehensive Cancer Network Guidelines
06/22/2021
Can you identify which option coincides with the National Comprehensive Cancer Network guidelines supporting Dr Srivastava’s statement?
Can you identify which option coincides with the National Comprehensive Cancer Network guidelines supporting Dr Srivastava’s statement?
Can you identify which option...
06/22/2021
The Dermatologist
eee
Quiz
Pediatric Melanoma Anatomical Site
06/15/2021
Which of the following accurately describes the results of a study published in Laryngoscope?
Which of the following accurately describes the results of a study published in Laryngoscope?
Which of the following...
06/15/2021
The Dermatologist
Quiz
Maximizing Photoprotective Behaviors
04/15/2021
A recent study found that sunscreen use, long-sleeved shirt use, and shade-seeking behavior are inadequate in which two groups?
A recent study found that sunscreen use, long-sleeved shirt use, and shade-seeking behavior are inadequate in which two groups?
A recent study found that...
04/15/2021
The Dermatologist
Quiz
What's Your Dx: Thickened and Discolored Nail
11/13/2020
A 62-year-old White man presented with nail changes on his left third finger. He described an initial thickening and discoloration of his nail of 1 year that progressed more rapidly over the last 12 months to the current presentation. What`s...
A 62-year-old White man presented with nail changes on his left third finger. He described an initial thickening and discoloration of his nail of 1 year that progressed more rapidly over the last 12 months to the current presentation. What`s...
A 62-year-old White man...
11/13/2020
The Dermatologist
Quiz
Type 2 Endotypes and Therapeutic Strategy in Prurigo Nodularis
06/25/2026
Riya Gandhi, MA
Assess advanced concepts in type 2 inflammatory endotypes, shared therapeutic pathways, and practical treatment approaches in prurigo nodularis.
Assess advanced concepts in type 2 inflammatory endotypes, shared therapeutic pathways, and practical treatment approaches in prurigo nodularis.
Assess advanced concepts in type...
06/25/2026
The Dermatologist
itch
Quiz
Fibrosis and Persistent Itch in Prurigo Nodularis
06/15/2026
Riya Gandhi, MA
Test your clinical understanding of fibrotic remodeling and the mechanisms underlying persistent itch and chronic disease activity in prurigo nodularis.
Test your clinical understanding of fibrotic remodeling and the mechanisms underlying persistent itch and chronic disease activity in prurigo nodularis.
Test your clinical understanding...
06/15/2026
The Dermatologist
brain
Quiz
Neuroimmune Mechanisms and Cytokine Signaling in Prurigo Nodularis
06/05/2026
Riya Gandhi, MA
Explore advanced concepts in neuroimmune communication, cytokine-driven itch amplification, and fibrotic signaling pathways involved in prurigo nodularis.
Explore advanced concepts in neuroimmune communication, cytokine-driven itch amplification, and fibrotic signaling pathways involved in prurigo nodularis.
Explore advanced concepts in...
06/05/2026
The Dermatologist
Quiz
Predicting Disease Severity and Persistence in Pediatric Atopic Dermatitis
04/15/2026
Riya Gandhi, MA
Test your expertise in identifying risk factors for persistent pediatric atopic dermatitis and understanding the interplay between barrier dysfunction and immune dysregulation.
Test your expertise in identifying risk factors for persistent pediatric atopic dermatitis and understanding the interplay between barrier dysfunction and immune dysregulation.
Test your expertise in...
04/15/2026
The Dermatologist
Quiz
Type 2 Inflammation and Early Systemic Therapy in Pediatric Atopic Dermatitis
04/05/2026
Riya Gandhi, MA
Assess advanced clinical reasoning in pediatric atopic dermatitis, including implications of type 2 inflammation for diagnosis, treatment timing, and systemic therapy decisions.
Assess advanced clinical reasoning in pediatric atopic dermatitis, including implications of type 2 inflammation for diagnosis, treatment timing, and systemic therapy decisions.
Assess advanced clinical...
04/05/2026
The Dermatologist
Quiz
Disease Heterogeneity in PN
03/15/2026
Riya Gandhi, MA
Challenge your understanding of direct and indirect cytokine–nerve interactions and mechanical hypersensitivity of type 2 signaling in prurigo nodularis.
Challenge your understanding of direct and indirect cytokine–nerve interactions and mechanical hypersensitivity of type 2 signaling in prurigo nodularis.
Challenge your understanding of...
03/15/2026
The Dermatologist
Quiz
Rethinking Severity and JAK Inhibitor Strategy in Alopecia Areata
03/12/2026
Riya Gandhi, MA
How should clinicians redefine severe alopecia areata? When is it appropriate to treat ≤20% scalp involvement with oral JAK inhibitors? This expert-level quiz explores remission durability, treatment withdrawal, and practical strategies for...
How should clinicians redefine severe alopecia areata? When is it appropriate to treat ≤20% scalp involvement with oral JAK inhibitors? This expert-level quiz explores remission durability, treatment withdrawal, and practical strategies for...
How should clinicians redefine...
03/12/2026
The Dermatologist
Quiz
Cytokine Hierarchy and Sustained Pruritus in PN
03/10/2026
Riya Gandhi, MA
Explore the hierarchical and cooperative roles of IL-4, IL-13, and IL-31 in sustaining chronic itch and inflammation in prurigo nodularis.
Explore the hierarchical and cooperative roles of IL-4, IL-13, and IL-31 in sustaining chronic itch and inflammation in prurigo nodularis.
Explore the hierarchical and...
03/10/2026
The Dermatologist
Quiz
Type 2 Inflammation as a Pathogenic Driver in Prurigo Nodularis
03/05/2026
Riya Gandhi, MA
Test your understanding of how type 2 immune signaling drives chronic itch in prurigo nodularis through complex neuroimmune interactions.
Test your understanding of how type 2 immune signaling drives chronic itch in prurigo nodularis through complex neuroimmune interactions.
Test your understanding of how...
03/05/2026
The Dermatologist
psoriasis
Quiz
Distinguishing Feature of Generalized Pustular Psoriasis
03/02/2026
Jessica Garlewicz
What is a key distinguishing feature of generalized pustular psoriasis that differentiates it from plaque psoriasis?
What is a key distinguishing feature of generalized pustular psoriasis that differentiates it from plaque psoriasis?
What is a key distinguishing...
03/02/2026
The Dermatologist

News

skin cancer
News
Phase 3 Trial Demonstrates Significant Benefits of Libtayo in High-Risk Cutaneous Squamous Cell Carcinoma
01/14/2025
Jessica Garlewicz
Regeneron Pharmaceuticals has announced promising interim results from the Phase 3 C-POST trial, evaluating the PD-1 inhibitor Libtayo (cemiplimab).
Regeneron Pharmaceuticals has announced promising interim results from the Phase 3 C-POST trial, evaluating the PD-1 inhibitor Libtayo (cemiplimab).
Regeneron Pharmaceuticals has...
01/14/2025
The Dermatologist
doctor
News
Pongamia Pinnata Extract as a Potential Treatment for Skin Cancer
12/30/2024
Riya Gandhi, MA
New research reveals Pongamia pinnata’s powerful potential as an anti-cancer agent for skin tumors, combining traditional knowledge with cutting-edge molecular science.
New research reveals Pongamia pinnata’s powerful potential as an anti-cancer agent for skin tumors, combining traditional knowledge with cutting-edge molecular science.
New research reveals Pongamia...
12/30/2024
The Dermatologist
skin cancer
News
Non-Melanoma Skin Cancer Event Rates: Considerations for Clinical Trial Design
08/22/2024
Jessica Garlewicz
Researchers investigated clinical risk factors and event rates for the development of new non-melanoma skin cancer.
Researchers investigated clinical risk factors and event rates for the development of new non-melanoma skin cancer.
Researchers investigated...
08/22/2024
The Dermatologist
skin cancer
News
Skin Cancers Associated with Genodermatoses in Patients with Skin of Color
08/09/2024
Jessica Garlewicz
Researchers aimed to identify notable characteristics in location, frequency, and severity of cutaneous findings, along with the median age of skin cancers in patients with skin of color.
Researchers aimed to identify notable characteristics in location, frequency, and severity of cutaneous findings, along with the median age of skin cancers in patients with skin of color.
Researchers aimed to identify...
08/09/2024
The Dermatologist
skin cancer
News
Esophageal Squamous Cell Carcinoma Under Iodine Staining
08/09/2024
Jessica Garlewicz
Researchers aimed to evaluate the effects of texture and color enhancement imaging on improving the endoscopic visibility of esophageal squamous cell carcinoma under iodine staining.
Researchers aimed to evaluate the effects of texture and color enhancement imaging on improving the endoscopic visibility of esophageal squamous cell carcinoma under iodine staining.
Researchers aimed to evaluate...
08/09/2024
The Dermatologist
skin cancer
News
Establishing a Novel Model for Studying Neural Invasion in Non-Melanoma Skin Cancer
05/15/2024
Jessica Garlewicz
Researchers aimed to develop a 3-dimensional model of neural invasion in squamous cell carcinoma to better understand its underlying biologic mechanisms, which are still poorly understood.
Researchers aimed to develop a 3-dimensional model of neural invasion in squamous cell carcinoma to better understand its underlying biologic mechanisms, which are still poorly understood.
Researchers aimed to develop a...
05/15/2024
The Dermatologist
skin cancer
News
Interferon-Gamma as a Prognostic Marker in Macroscopic Stage III Melanoma
05/08/2024
Jessica Garlewicz
Researchers aimed to identify prognostic and predictive biomarkers for adjuvant anti-PD-1 therapy in patients with macroscopic stage III melanoma.
Researchers aimed to identify prognostic and predictive biomarkers for adjuvant anti-PD-1 therapy in patients with macroscopic stage III melanoma.
Researchers aimed to identify...
05/08/2024
The Dermatologist
skin cancer
News
Relationship Between Insulin Use, Social Determinants of Health, and Non-Melanoma Skin Cancer
05/07/2024
Jessica Garlewicz
Researchers aimed to investigate the relationship between insulin use, social determinants of health, and non-melanoma skin cancer risk among individuals with diabetes.
Researchers aimed to investigate the relationship between insulin use, social determinants of health, and non-melanoma skin cancer risk among individuals with diabetes.
Researchers aimed to investigate...
05/07/2024
The Dermatologist
skin cancer
News
Regulatory T Cell Involvement in Melanoma Prognosis and Treatment Strategy
03/28/2024
Jessica Garlewicz
Researchers analyzed single-cell RNA sequencing data alongside clinical information.
Researchers analyzed single-cell RNA sequencing data alongside clinical information.
Researchers analyzed single-cell...
03/28/2024
The Dermatologist
skin cancer
News
Role of Cuproptosis and Hippo Pathway in the Prognosis of Skin Cutaneous Melanoma
03/28/2024
Jessica Garlewicz
Researchers examined the correlation between cuproptosis-related and Hippo pathway-related genes and melanoma prognosis using public databases and experimental validation.
Researchers examined the correlation between cuproptosis-related and Hippo pathway-related genes and melanoma prognosis using public databases and experimental validation.
Researchers examined the...
03/28/2024
The Dermatologist
FDA Alerts
FDA Grants Accelerated Approval to Tudriqev for PD-1-Refractory Advanced Melanoma
08/07/2026
Jessica Garlewicz
The US Food and Drug Administration (FDA) has granted accelerated approval to Tudriqev (vusolimogene oderparepvec-wtpg) in combination with nivolumab for the treatment of adults with unresectable advanced cutaneous melanoma.
The US Food and Drug Administration (FDA) has granted accelerated approval to Tudriqev (vusolimogene oderparepvec-wtpg) in combination with nivolumab for the treatment of adults with unresectable advanced cutaneous melanoma.
The US Food and Drug...
08/07/2026
The Dermatologist
roflum
FDA Alerts
FDA Approves Roflumilast Cream 0.3% for Plaque Psoriasis in Children as Young as 2 Years
06/30/2026
Riya Gandhi, MA
The expanded indication makes roflumilast cream 0.3% the first once-daily, steroid-free topical therapy approved for plaque psoriasis in children aged 2 years and older, providing a new long-term treatment option for pediatric patients.
The expanded indication makes roflumilast cream 0.3% the first once-daily, steroid-free topical therapy approved for plaque psoriasis in children aged 2 years and older, providing a new long-term treatment option for pediatric patients.
The expanded indication makes...
06/30/2026
The Dermatologist
FDA Alert
FDA Alerts
FDA Approves Every-8-Week Maintenance Dosing Option for Lebrikizumab in Atopic Dermatitis
06/10/2026
Jessica Garlewicz
The FDA approved an every-8-week maintenance dosing regimen for Ebglyss (lebrikizumab-lbkz), providing a new administration option for adults and adolescents aged 12 years and older weighing at least 40 kg with moderate-to-severe atopic...
The FDA approved an every-8-week maintenance dosing regimen for Ebglyss (lebrikizumab-lbkz), providing a new administration option for adults and adolescents aged 12 years and older weighing at least 40 kg with moderate-to-severe atopic...
The FDA approved an every-8-week...
06/10/2026
The Dermatologist
psoriasis0
News
Altered Lysine Crotonylation Identified in Psoriatic Skin
03/19/2026
Jessica Garlewicz
Lysine crotonylation, a post-translational modification previously studied in oncology, may play a role in psoriasis pathogenesis, according to a translational study comparing protein modification profiles in lesional and non-lesional skin.
Lysine crotonylation, a post-translational modification previously studied in oncology, may play a role in psoriasis pathogenesis, according to a translational study comparing protein modification profiles in lesional and non-lesional skin.
Lysine crotonylation, a...
03/19/2026
The Dermatologist
FDA Alerts
FDA Approves Icotyde (icotrokinra) for the Treatment of Moderate-To-Severe Plaque Psoriasis in Adults and Pediatric Patients
03/18/2026
Jessica Garlewicz
The US Food and Drug Administration approved Icotyde (icotrokinra) for the treatment of moderate-to-severe plaque psoriasis in adults and pediatric patients aged 12 years and older.
The US Food and Drug Administration approved Icotyde (icotrokinra) for the treatment of moderate-to-severe plaque psoriasis in adults and pediatric patients aged 12 years and older.
The US Food and Drug...
03/18/2026
The Dermatologist
FDA Alerts
FDA Approves Cosentyx for the Treatment of Pediatric Patients Aged 12 Years and Older With Moderate-To-Severe Hidradenitis Suppurativa
03/17/2026
Jessica Garlewicz
The US Food and Drug Administration approved Cosentyx for the treatment of pediatric patients aged 12 years and older with moderate-to-severe hidradenitis suppurativa.
The US Food and Drug Administration approved Cosentyx for the treatment of pediatric patients aged 12 years and older with moderate-to-severe hidradenitis suppurativa.
The US Food and Drug...
03/17/2026
The Dermatologist
AD
News
Mixed Associations Between Socioeconomic Status and Pediatric Atopic Dermatitis Highlight Research Gaps
03/11/2026
Jessica Garlewicz
Socioeconomic status appears to influence pediatric atopic dermatitis, but the direction and strength of the association remain unclear.
Socioeconomic status appears to influence pediatric atopic dermatitis, but the direction and strength of the association remain unclear.
Socioeconomic status appears to...
03/11/2026
The Dermatologist
FDA Alerts
FDA Approves Sotyktu for the Treatment of Adults with Active Psoriatic Arthritis
03/10/2026
Jessica Garlewicz
On March 6, 2026, the US Food and Drug Administration approved Sotyktu (deucravacitinib) for the treatment of adults with active psoriatic arthritis.
On March 6, 2026, the US Food and Drug Administration approved Sotyktu (deucravacitinib) for the treatment of adults with active psoriatic arthritis.
On March 6, 2026, the US Food...
03/10/2026
The Dermatologist
random
News
Biologic Therapy Improves Psychological Well-Being and Quality of Life in Psoriasis
03/03/2026
Jessica Garlewicz
Biologic therapy for moderate-to-severe plaque psoriasis was associated with marked improvements in psychological distress and quality of life in a real-world clinical setting.
Biologic therapy for moderate-to-severe plaque psoriasis was associated with marked improvements in psychological distress and quality of life in a real-world clinical setting.
Biologic therapy for...
03/03/2026
The Dermatologist
psoriasis
News
Low Prevalence but Meaningful Impact of Psychological Symptoms Seen in Well-Controlled Psoriasis
02/03/2026
Jessica Garlewicz
Anxiety and depression symptoms can still occur in young adults with well-controlled psoriasis, even when disease activity is minimal, according to a cross-sectional study exploring psychological distress and its potential biological...
Anxiety and depression symptoms can still occur in young adults with well-controlled psoriasis, even when disease activity is minimal, according to a cross-sectional study exploring psychological distress and its potential biological...
Anxiety and depression symptoms...
02/03/2026
The Dermatologist
July/August 2026

Current Issue

August 2026
Volume 34
Issue 5
Current Issue
Issue Archive
The Dermatologist Newsletter

Recent News

skin cancer
News
Phase 3 Trial Demonstrates Significant Benefits of Libtayo in High-Risk Cutaneous Squamous Cell Carcinoma
01/14/2025
Jessica Garlewicz
Regeneron Pharmaceuticals has announced promising interim results from the Phase 3 C-POST trial, evaluating the PD-1 inhibitor Libtayo (cemiplimab).
Regeneron Pharmaceuticals has announced promising interim results from the Phase 3 C-POST trial, evaluating the PD-1 inhibitor Libtayo (cemiplimab).
Regeneron Pharmaceuticals has...
01/14/2025
The Dermatologist
doctor
News
Pongamia Pinnata Extract as a Potential Treatment for Skin Cancer
12/30/2024
Riya Gandhi, MA
New research reveals Pongamia pinnata’s powerful potential as an anti-cancer agent for skin tumors, combining traditional knowledge with cutting-edge molecular science.
New research reveals Pongamia pinnata’s powerful potential as an anti-cancer agent for skin tumors, combining traditional knowledge with cutting-edge molecular science.
New research reveals Pongamia...
12/30/2024
The Dermatologist
skin cancer
News
Non-Melanoma Skin Cancer Event Rates: Considerations for Clinical Trial Design
08/22/2024
Jessica Garlewicz
Researchers investigated clinical risk factors and event rates for the development of new non-melanoma skin cancer.
Researchers investigated clinical risk factors and event rates for the development of new non-melanoma skin cancer.
Researchers investigated...
08/22/2024
The Dermatologist
skin cancer
News
Skin Cancers Associated with Genodermatoses in Patients with Skin of Color
08/09/2024
Jessica Garlewicz
Researchers aimed to identify notable characteristics in location, frequency, and severity of cutaneous findings, along with the median age of skin cancers in patients with skin of color.
Researchers aimed to identify notable characteristics in location, frequency, and severity of cutaneous findings, along with the median age of skin cancers in patients with skin of color.
Researchers aimed to identify...
08/09/2024
The Dermatologist
skin cancer
News
Esophageal Squamous Cell Carcinoma Under Iodine Staining
08/09/2024
Jessica Garlewicz
Researchers aimed to evaluate the effects of texture and color enhancement imaging on improving the endoscopic visibility of esophageal squamous cell carcinoma under iodine staining.
Researchers aimed to evaluate the effects of texture and color enhancement imaging on improving the endoscopic visibility of esophageal squamous cell carcinoma under iodine staining.
Researchers aimed to evaluate...
08/09/2024
The Dermatologist
skin cancer
News
Establishing a Novel Model for Studying Neural Invasion in Non-Melanoma Skin Cancer
05/15/2024
Jessica Garlewicz
Researchers aimed to develop a 3-dimensional model of neural invasion in squamous cell carcinoma to better understand its underlying biologic mechanisms, which are still poorly understood.
Researchers aimed to develop a 3-dimensional model of neural invasion in squamous cell carcinoma to better understand its underlying biologic mechanisms, which are still poorly understood.
Researchers aimed to develop a...
05/15/2024
The Dermatologist
skin cancer
News
Interferon-Gamma as a Prognostic Marker in Macroscopic Stage III Melanoma
05/08/2024
Jessica Garlewicz
Researchers aimed to identify prognostic and predictive biomarkers for adjuvant anti-PD-1 therapy in patients with macroscopic stage III melanoma.
Researchers aimed to identify prognostic and predictive biomarkers for adjuvant anti-PD-1 therapy in patients with macroscopic stage III melanoma.
Researchers aimed to identify...
05/08/2024
The Dermatologist
skin cancer
News
Relationship Between Insulin Use, Social Determinants of Health, and Non-Melanoma Skin Cancer
05/07/2024
Jessica Garlewicz
Researchers aimed to investigate the relationship between insulin use, social determinants of health, and non-melanoma skin cancer risk among individuals with diabetes.
Researchers aimed to investigate the relationship between insulin use, social determinants of health, and non-melanoma skin cancer risk among individuals with diabetes.
Researchers aimed to investigate...
05/07/2024
The Dermatologist
skin cancer
News
Regulatory T Cell Involvement in Melanoma Prognosis and Treatment Strategy
03/28/2024
Jessica Garlewicz
Researchers analyzed single-cell RNA sequencing data alongside clinical information.
Researchers analyzed single-cell RNA sequencing data alongside clinical information.
Researchers analyzed single-cell...
03/28/2024
The Dermatologist
skin cancer
News
Role of Cuproptosis and Hippo Pathway in the Prognosis of Skin Cutaneous Melanoma
03/28/2024
Jessica Garlewicz
Researchers examined the correlation between cuproptosis-related and Hippo pathway-related genes and melanoma prognosis using public databases and experimental validation.
Researchers examined the correlation between cuproptosis-related and Hippo pathway-related genes and melanoma prognosis using public databases and experimental validation.
Researchers examined the...
03/28/2024
The Dermatologist
FDA Alerts
FDA Grants Accelerated Approval to Tudriqev for PD-1-Refractory Advanced Melanoma
08/07/2026
Jessica Garlewicz
The US Food and Drug Administration (FDA) has granted accelerated approval to Tudriqev (vusolimogene oderparepvec-wtpg) in combination with nivolumab for the treatment of adults with unresectable advanced cutaneous melanoma.
The US Food and Drug Administration (FDA) has granted accelerated approval to Tudriqev (vusolimogene oderparepvec-wtpg) in combination with nivolumab for the treatment of adults with unresectable advanced cutaneous melanoma.
The US Food and Drug...
08/07/2026
The Dermatologist
roflum
FDA Alerts
FDA Approves Roflumilast Cream 0.3% for Plaque Psoriasis in Children as Young as 2 Years
06/30/2026
Riya Gandhi, MA
The expanded indication makes roflumilast cream 0.3% the first once-daily, steroid-free topical therapy approved for plaque psoriasis in children aged 2 years and older, providing a new long-term treatment option for pediatric patients.
The expanded indication makes roflumilast cream 0.3% the first once-daily, steroid-free topical therapy approved for plaque psoriasis in children aged 2 years and older, providing a new long-term treatment option for pediatric patients.
The expanded indication makes...
06/30/2026
The Dermatologist
FDA Alert
FDA Alerts
FDA Approves Every-8-Week Maintenance Dosing Option for Lebrikizumab in Atopic Dermatitis
06/10/2026
Jessica Garlewicz
The FDA approved an every-8-week maintenance dosing regimen for Ebglyss (lebrikizumab-lbkz), providing a new administration option for adults and adolescents aged 12 years and older weighing at least 40 kg with moderate-to-severe atopic...
The FDA approved an every-8-week maintenance dosing regimen for Ebglyss (lebrikizumab-lbkz), providing a new administration option for adults and adolescents aged 12 years and older weighing at least 40 kg with moderate-to-severe atopic...
The FDA approved an every-8-week...
06/10/2026
The Dermatologist
psoriasis0
News
Altered Lysine Crotonylation Identified in Psoriatic Skin
03/19/2026
Jessica Garlewicz
Lysine crotonylation, a post-translational modification previously studied in oncology, may play a role in psoriasis pathogenesis, according to a translational study comparing protein modification profiles in lesional and non-lesional skin.
Lysine crotonylation, a post-translational modification previously studied in oncology, may play a role in psoriasis pathogenesis, according to a translational study comparing protein modification profiles in lesional and non-lesional skin.
Lysine crotonylation, a...
03/19/2026
The Dermatologist
FDA Alerts
FDA Approves Icotyde (icotrokinra) for the Treatment of Moderate-To-Severe Plaque Psoriasis in Adults and Pediatric Patients
03/18/2026
Jessica Garlewicz
The US Food and Drug Administration approved Icotyde (icotrokinra) for the treatment of moderate-to-severe plaque psoriasis in adults and pediatric patients aged 12 years and older.
The US Food and Drug Administration approved Icotyde (icotrokinra) for the treatment of moderate-to-severe plaque psoriasis in adults and pediatric patients aged 12 years and older.
The US Food and Drug...
03/18/2026
The Dermatologist
FDA Alerts
FDA Approves Cosentyx for the Treatment of Pediatric Patients Aged 12 Years and Older With Moderate-To-Severe Hidradenitis Suppurativa
03/17/2026
Jessica Garlewicz
The US Food and Drug Administration approved Cosentyx for the treatment of pediatric patients aged 12 years and older with moderate-to-severe hidradenitis suppurativa.
The US Food and Drug Administration approved Cosentyx for the treatment of pediatric patients aged 12 years and older with moderate-to-severe hidradenitis suppurativa.
The US Food and Drug...
03/17/2026
The Dermatologist
AD
News
Mixed Associations Between Socioeconomic Status and Pediatric Atopic Dermatitis Highlight Research Gaps
03/11/2026
Jessica Garlewicz
Socioeconomic status appears to influence pediatric atopic dermatitis, but the direction and strength of the association remain unclear.
Socioeconomic status appears to influence pediatric atopic dermatitis, but the direction and strength of the association remain unclear.
Socioeconomic status appears to...
03/11/2026
The Dermatologist
FDA Alerts
FDA Approves Sotyktu for the Treatment of Adults with Active Psoriatic Arthritis
03/10/2026
Jessica Garlewicz
On March 6, 2026, the US Food and Drug Administration approved Sotyktu (deucravacitinib) for the treatment of adults with active psoriatic arthritis.
On March 6, 2026, the US Food and Drug Administration approved Sotyktu (deucravacitinib) for the treatment of adults with active psoriatic arthritis.
On March 6, 2026, the US Food...
03/10/2026
The Dermatologist
random
News
Biologic Therapy Improves Psychological Well-Being and Quality of Life in Psoriasis
03/03/2026
Jessica Garlewicz
Biologic therapy for moderate-to-severe plaque psoriasis was associated with marked improvements in psychological distress and quality of life in a real-world clinical setting.
Biologic therapy for moderate-to-severe plaque psoriasis was associated with marked improvements in psychological distress and quality of life in a real-world clinical setting.
Biologic therapy for...
03/03/2026
The Dermatologist
psoriasis
News
Low Prevalence but Meaningful Impact of Psychological Symptoms Seen in Well-Controlled Psoriasis
02/03/2026
Jessica Garlewicz
Anxiety and depression symptoms can still occur in young adults with well-controlled psoriasis, even when disease activity is minimal, according to a cross-sectional study exploring psychological distress and its potential biological...
Anxiety and depression symptoms can still occur in young adults with well-controlled psoriasis, even when disease activity is minimal, according to a cross-sectional study exploring psychological distress and its potential biological...
Anxiety and depression symptoms...
02/03/2026
The Dermatologist

HMP Global Products

Events

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2026 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Terms of Use